These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9639299)
1. Intracellular metabolism of 99mTc-d,l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain. Fujibayashi Y; Taniuchi H; Waki A; Yokoyama A; Ishii Y; Yonekura Y Nucl Med Biol; 1998 May; 25(4):375-8. PubMed ID: 9639299 [TBL] [Abstract][Full Text] [Related]
2. Distribution of glutathione and technetium-99m-meso-HMPAO in normal and diethyl maleate-treated mouse brain mitochondria. Sasaki T; Fujibayashi Y; Senda M J Nucl Med; 1998 Dec; 39(12):2178-83. PubMed ID: 9867165 [TBL] [Abstract][Full Text] [Related]
3. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime. Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448 [TBL] [Abstract][Full Text] [Related]
4. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction. Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and metabolic state of hyperfixation with 99mTc-HMPAO brain SPECT in subacute stroke. Cho I; Hayashida K; Imakita S; Kume N; Fukuchi K Ann Nucl Med; 2000 Jun; 14(3):159-63. PubMed ID: 10921479 [TBL] [Abstract][Full Text] [Related]
6. Effect of metabolic alterations on the accumulation of technetium-99m-labeled d,l-HMPAO in slices of rat cerebral cortex. Ahn CS; Tow DE; Yu CC; Greene RW J Cereb Blood Flow Metab; 1994 Mar; 14(2):324-31. PubMed ID: 8113327 [TBL] [Abstract][Full Text] [Related]
7. New insights on flow-independent mechanisms of 99mTc-HMPAO retention in nervous tissue: in vitro study. Colamussi P; Calò G; Sbrenna S; Uccelli L; Bianchi C; Cittanti C; Siniscalchi A; Giganti M; Roveri R; Piffanelli A J Nucl Med; 1999 Sep; 40(9):1556-62. PubMed ID: 10492379 [TBL] [Abstract][Full Text] [Related]
8. Astrocytes as a predominant cellular site of (99m)Tc-HMPAO retention. Zerarka S; Pellerin L; Slosman D; Magistretti PJ J Cereb Blood Flow Metab; 2001 Apr; 21(4):456-68. PubMed ID: 11323531 [TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-meso-HMPAO as a potential agent to image cerebral glutathione content. Sasaki T; Senda M J Nucl Med; 1997 Jul; 38(7):1125-9. PubMed ID: 9225804 [TBL] [Abstract][Full Text] [Related]
10. Increased uptake of 99mTc-HMPAO in necrotic brain tumors. Lee SH; Choi CW; Kim JH; Rhee CH; Lim SM J Korean Med Sci; 1998 Oct; 13(5):529-32. PubMed ID: 9811184 [TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-hexamethylpropylene amine oxime lung scintigraphy findings in patients with Behçet's disease. Gumuser G; Pirildar T; Tarhan S; Batok D; Ruksen E; Sakar A; Sayit E Nucl Med Commun; 2011 May; 32(5):363-8. PubMed ID: 21394049 [TBL] [Abstract][Full Text] [Related]
12. Assessment of antioxidative ability in brain: technetium-99m-meso-HMPAO as an imaging agent for glutathione localization. Sasaki T; Toyama H; Oda K; Ogihara-Umeda I; Nishigori H; Senda M J Nucl Med; 1996 Oct; 37(10):1698-701. PubMed ID: 8862315 [TBL] [Abstract][Full Text] [Related]
13. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes. Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of (99m)Tc-d,l-HMPAO for estimation of GSH content in tumor tissues. Shimura N; Musya A; Hashimoto T; Kojima S; Kubodera A; Sasaki T Nucl Med Biol; 2000 Aug; 27(6):577-80. PubMed ID: 11056372 [TBL] [Abstract][Full Text] [Related]
15. Stabilisation of high-activity 99mTc-d,l-HMPAO preparations with cobalt chloride and their biological behaviour. Mang'era KO; Vanbilloen HP; Schiepers CW; Verbruggen AM Eur J Nucl Med; 1995 Oct; 22(10):1163-72. PubMed ID: 8542901 [TBL] [Abstract][Full Text] [Related]
16. In vivo metabolism and kinetics of 99mTc-HMPAO. Lucignani G; Rossetti C; Ferrario P; Zecca L; Gilardi MC; Zito F; Perani D; Lenzi GL; Fazio F Eur J Nucl Med; 1990; 16(4-6):249-55. PubMed ID: 2351174 [TBL] [Abstract][Full Text] [Related]
17. Normal regional distribution of cerebral blood flow in dogs: comparison between (99m) Tc-ethylcysteinate dimer and (99m) Tc- hexamethylpropylene amine oxime single photon emission computed tomography. Adriaens A; Polis I; Waelbers T; Vandermeulen E; Dobbeleir A; De Spiegeleer B; Peremans K Vet Radiol Ultrasound; 2013; 54(4):403-407. PubMed ID: 23496105 [TBL] [Abstract][Full Text] [Related]
18. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk. Marshall DS; Newberry NR; Ryan PJ Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318 [TBL] [Abstract][Full Text] [Related]
19. An efficient HPLC method for the analysis of isomeric purity of technetium-99m-exametazime and identity confirmation using LC-MS. Vanderghinste D; Van Eeckhoudt M; Terwinghe C; Mortelmans L; Bormans GM; Verbruggen AM; Vanbilloen HP J Pharm Biomed Anal; 2003 Aug; 32(4-5):679-85. PubMed ID: 12899958 [TBL] [Abstract][Full Text] [Related]
20. Hyperfixation of 99mTc-HMPAO and hypofixation of 123I-iomazenil in acute herpes encephalitis. Launes J; Hokkanen L; Nikkinen P; Liewendahl K; Salonen O; Sirén J; Iivanainen M Neuroreport; 1995 May; 6(8):1203-6. PubMed ID: 7662908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]